Cross-recognition of HLADR4 alloantigen by virus-specific CD8+ T cells: A new paradigm for self-/nonself-recognition

Blood

Volumn 114, Issue 11, 2009, Pages 2244-2253

  Rist, Michael ^a   Smith, Corey ^a   Bell, Melissa J ^a   Burrows, Scott R ^a   Khanna, Rajiv ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR4 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; HLA C ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MATRIX PROTEIN; PEPTIDE; PHOSPHOPROTEIN;

ALLOTYPE; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL LINEAGE; CROSS REACTION; CYTOMEGALOVIRUS; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR BINDING; ALLOTRANSPLANTATION; CELL LINE; IMMUNOLOGY;

AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOMEGALOVIRUS; EPITOPES, T-LYMPHOCYTE; GRAFT REJECTION; HLA-C ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; PEPTIDES; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSPLANTATION, HOMOLOGOUS; VIRAL MATRIX PROTEINS;

EID: 70349569997     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-222596     Document Type: Article

References (40)

1. + T-cell memory to viruses. Curr Opin Immunol. 1994;6(4):545-552.
2. + T-cell mechanisms in the control of respiratory virus infections. Immunol Rev. 1997;159(10):105-117.
3. Janeway CA. Thymic selection: two pathways to life and two to death. Immunity. 1994;1(1):3-6. (Pubitemid 124000690)
4. Nikolić-Zugić J, Bevan MJ. Role of self-peptides in positively selecting the T-cell repertoire. Nature. 1990;344(6261):65-67. (Pubitemid 20073236)
5. Zinkernagel RM, Bachmann MF, Kundig TM, Oehen S, Pirchet H, Hengartner H. On immunological memory. Annu Rev Immunol. 1996;14:333(67):333-367.
6. Marrack P, Lo D, Brinster R, Palmiter R, Burkly L, Flavell RH. The effect of thymus environment on T-cell development and tolerance. Cell. 1988;53(4):627-634.
7. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T-cell receptor antagonist peptides induce positive selection. Cell. 1994;76(1):17-27. (Pubitemid 24035278)
8. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5(10):772-782.
9. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 1989;341(6244):746-749.
10. + single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med. 1994;180(1):25-34.
11. Garcia KC, Teyton L, Wilson IA. Structural basis of T cell recognition. Annu Rev Immunol. 1999;17:369-397.
12. Rudensky AYu, Rath S, Preston-Hurlburt P, Murphy DB, Janeway CA Jr. On the complexity of self. Nature. 1991;353(6345):660-662.
13. Burrows SR, Khanna R, Silins SL, Moss DJ. The influence of antiviral T-cell responses on the alloreactive repertoire. Immunol Today. 1999;20(5):203-207. (Pubitemid 29217074)
14. Archbold JK, Macdonald WA, Burrows SR, Rossjohn J, McCluskey J. T-cell allorecognition: a case of mistaken identity or deja vu?. Trends Immunol. 2008;29(5):220-226.
15. Heemskerk MH, de Paus RA, Lurvink EG, et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T-cell receptor complex. Proc Natl Acad Sci U S A. 2001;98(12):6806-6811.
16. + cytolytic T lymphocytes. Proc Natl Acad Sci U S A. 2003;100(19):10896-10901.
17. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med. 1994;179(4):1155-1161. (Pubitemid 24091774)
18. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T-cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med. 1995;182(6):1703-1715.
19. Burrows SR, Silins SL, Khanna R, et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol. 1997;27(7):1726-1736. (Pubitemid 27302856)
20. Archbold JK, Macdonald WA, Gras S, et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med. 2009;206(1):209-219.
21. Archbold JK, Ely LK, Kjer-Nielsen L, et al. T-cell allorecognition and MHC restriction - A case of Jekyll and Hyde? Mol Immunol. 2008;45(3):583-598. (Pubitemid 47498588)
22. Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 1986;5(5):943-949.
23. Elkington R, Walker S, Crough T, et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol. 2003;77(9):5226-5240. (Pubitemid 36460937)
24. Khanna R, Burrows SR, Kurilla MG, et al. Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med. 1992;176(1):169-176.
25. Panzara MA, Gussoni E, Steinman L, Oksenberg JR. Analysis of the T-cell repertoire using the PCR and specific oligonucleotide primers. Biotechniques. 1992;12(5):728-735.
26. Sette A, Sidney J, Oseroff C, et al. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J Immunol. 1993;151(6):3163-3170. (Pubitemid 23282627)
27. Hammer J, Gallazzi F, Bono E, et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med. 1995;181(5):1847-1855.
28. Honeyman MC, Brusic V, Stone NL, Harrison LC. Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol. 1998;16(10):966-969. (Pubitemid 28483627)
29. Gregersen PK, Shen M, Song QL, et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A. 1986;83:2642-2646.
30. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics. 1991;33:267-275.
31. Burrows SR, Khanna R, Moss DJ. Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism. Blood. 1999;93(3):1020-1024. (Pubitemid 29067867)
32. Burrows SR, Khanna R, Silins SL, Moss DJ. The influence of antiviral T-cell responses on the alloreactive repertoire. Immunol Today. 1999;20(3):203-207. (Pubitemid 29217074)
33. + cytotoxic T lymphocytes: implications for graft-versus-host disease. Blood. 2005;105(3):1362-1364.
34. Harkiolaki M, Holmes SL, Svendsen P, et al. T-cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity. 2009;30(3):348-357.
35. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLADRB4 0101-restricted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med. 1995;181(5):1835-1845.
36. Feng S, Barthold SW, Bockenstedt LK, Zaller DM, Fikrig E. Lyme disease in human DR4Dw4-transgenic mice. J Infect Dis. 1995;172(1):286-289.
37. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6(12):883-894. (Pubitemid 44851731)
38. Eastmond CJ. Psoriatic arthritis. Genetics and HLA antigens. Baillieres Clin Rheumatol. 1994;8(2):263-276.
39. Gerber LH, Murray CL, Perlman SG, et al. Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes. J Rheumatol. 1982;9(5):703-707.
40. Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J Rheumatol. 1986;13(3):586-592.